These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 8604553)
1. Aerosol exposure of pigs to viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces antibodies in bronchoalveolar lining fluids and serum, and protects against homologous challenge. Hensel A; Stockhofe-Zurwieden N; Ganter M; Petzoldt K Vet Microbiol; 1995 Nov; 47(1-2):27-41. PubMed ID: 8604553 [TBL] [Abstract][Full Text] [Related]
3. Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge. Hensel A; Stockhofe-Zurwieden N; Petzoldt K; Lubitz W Infect Immun; 1995 Aug; 63(8):3048-53. PubMed ID: 7622229 [TBL] [Abstract][Full Text] [Related]
4. Protective immunity following immunisation of pigs with aerosol of Actinobacillus pleuropneumoniae serotype 2. Loftager MK; Eriksen L; Aasted B; Nielsen R Res Vet Sci; 1993 Nov; 55(3):281-6. PubMed ID: 8284489 [TBL] [Abstract][Full Text] [Related]
5. Aerosol treatment of pigs with Actinobacillus pleuropneumoniae serotype 2: mucosal immunity and resistance against challenge. Loftager MK; Eriksen L; Nielsen R Adv Exp Med Biol; 1995; 371B():1611-4. PubMed ID: 7502867 [No Abstract] [Full Text] [Related]
6. Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses. Katinger A; Lubitz W; Szostak MP; Stadler M; Klein R; Indra A; Huter V; Hensel A J Biotechnol; 1999 Aug; 73(2-3):251-60. PubMed ID: 10486934 [TBL] [Abstract][Full Text] [Related]
7. Oral and aerosol immunization with viable or inactivated Actinobacillus pleuropneumoniae bacteria: antibody response to capsular polysaccharides in bronchoalveolar lavage fluids (BALF) and sera of pigs. Hensel A; Pabst R; Bunka S; Petzoldt K Clin Exp Immunol; 1994 Apr; 96(1):91-7. PubMed ID: 8149673 [TBL] [Abstract][Full Text] [Related]
8. Oral immunization with lung-pathogenic bacteria is protective against defined challenge in a pig aerosol infection model. Hensel A; Delventhal S; Windt H; Stockhofe-Zurwieden N; Pabst R; Petzoldt K Adv Exp Med Biol; 1995; 371B():803-6. PubMed ID: 7502901 [No Abstract] [Full Text] [Related]
9. A PCR assay used to study aerosol transmission of Actinobacillus pleuropneumoniae from samples of live pigs under experimental conditions. Savoye C; Jobert JL; Berthelot-Hérault F; Keribin AM; Cariolet R; Morvan H; Madec F; Kobisch M Vet Microbiol; 2000 May; 73(4):337-47. PubMed ID: 10781732 [TBL] [Abstract][Full Text] [Related]
10. Blood lymphocyte subsets in pigs vaccinated and challenged with Actinobacillus pleuropneumoniae. Appleyard GD; Furesz SE; Wilkie BN Vet Immunol Immunopathol; 2002 Jul; 86(3-4):221-8. PubMed ID: 12007888 [TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia. Haga Y; Ogino S; Ohashi S; Ajito T; Hashimoto K; Sawada T J Vet Med Sci; 1997 Feb; 59(2):115-20. PubMed ID: 9070983 [TBL] [Abstract][Full Text] [Related]
12. Oral immunization against porcine pleuropneumonia using the cubic phase of monoolein and purified toxins of Actinobacillus pleuropneumoniae. Lopez-Bermudez J; Quintanar-Guerrero D; Lara Puente H; Tórtora Perez J; Suárez Güemez F; Ciprián Carrasco A; Mendoza Elvira S Vaccine; 2014 Nov; 32(50):6805-11. PubMed ID: 25446832 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of serology, bacteriological isolation and polymerase chain reaction for the detection of pigs carrying Actinobacillus pleuropneumoniae in the upper respiratory tract after experimental infection. Chiers K; Donné E; Van Overbeke I; Ducatelle R; Haesebrouck F Vet Microbiol; 2002 Sep; 88(4):385-92. PubMed ID: 12220813 [TBL] [Abstract][Full Text] [Related]
14. Cross-protection between Actinobacillus pleuropneumoniae biotypes-serotypes in pigs. Haesebrouk F; Van de Kerkhof A; Dom P; Chiers K; Ducatelle R Vet Microbiol; 1996 Oct; 52(3-4):277-84. PubMed ID: 8972053 [TBL] [Abstract][Full Text] [Related]
15. Actinobacillus pleuropneumoniae infections in closed swine herds: infection patterns and serological profiles. Chiers K; Donné E; Van Overbeke I; Ducatelle R; Haesebrouck F Vet Microbiol; 2002 Apr; 85(4):343-52. PubMed ID: 11856584 [TBL] [Abstract][Full Text] [Related]
16. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 10 of pigs vaccinated with bacterins consisting of A. pleuropneumoniae serotype 10 grown under NAD-rich and NAD-restricted conditions. van Overbeke I; Chiers K; Donne E; Ducatelle R; Haesebrouck F J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):289-93. PubMed ID: 14629000 [TBL] [Abstract][Full Text] [Related]
17. Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae. Byrd W; Harmon BG; Kadis S Vet Immunol Immunopathol; 1992 Nov; 34(3-4):307-24. PubMed ID: 1455686 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of granulomatous pleuropneumonia associated with Actinobacillus pleuropneumoniae serotype 2 in slaughter pigs. Ohba T; Shibahara T; Kobayashi H; Takashima A; Nagoshi M; Araki M; Takizawa K; Kubo M J Vet Med Sci; 2009 Aug; 71(8):1089-92. PubMed ID: 19721364 [TBL] [Abstract][Full Text] [Related]
19. Serotyping Actinobacillus pleuropneumoniae by the use of monoclonal antibodies. Lacouture S; Mittal KR; Jacques M; Gottschalk M J Vet Diagn Invest; 1997 Jul; 9(3):337-41. PubMed ID: 9249182 [No Abstract] [Full Text] [Related]
20. Lymphocyte subsets in bronchoalveolar lavage after exposure to Actinobacillus pleuropneumoniae in pigs previously immunized orally or by aerosol. Pabst R; Delventhal S; Gebert A; Hensel A; Petzoldt K Lung; 1995; 173(4):233-41. PubMed ID: 7564482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]